Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 1/20 | 0.31 |
| ▸ | TPMT | P51580 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL895353 | 0.87 | ALDH1A1 (0.41) | ALDH1A1ALOX15SMN1; SMN2KDM4ETSHR | |
| SCHEMBL11703883 | 0.87 | ALDH1A1 (0.41) | ALDH1A1ALOX15SMN1; SMN2KDM4ETSHR | |
| SCHEMBL11316478 | 0.87 | ALDH1A1 (0.41) | ALDH1A1ALOX15SMN1; SMN2KDM4ETSHR | |
| SCHEMBL7047489 | 0.87 | ALDH1A1 (0.41) | ALDH1A1ALOX15SMN1; SMN2KDM4ETSHR | |
| SCHEMBL11704719 | 0.87 | ALDH1A1 (0.41) | ALDH1A1ALOX15SMN1; SMN2KDM4ETSHR | |
| SCHEMBL7656107 | 0.83 | ALDH1A1 (0.42) | ALDH1A1ALOX15MAOBSMN1; SMN2KDM4E | |
| SCHEMBL9860412 | 0.83 | MAOB (0.39) | ALDH1A1ALOX15MAOBMAPT | |
| SCHEMBL9812995 | 0.81 | TSHR (0.41) | ALDH1A1ALOX15MAOBSMN1; SMN2KDM4E | |
| SCHEMBL2265112 | 0.81 | ALOX15 (0.37) | ALDH1A1ALOX15MAOBSMN1; SMN2MAPT | |
| SCHEMBL28525271 | 0.81 | ALDH1A1 (0.54) | ALDH1A1ALOX15SMN1; SMN2MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1084 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117654312-B | Preparation method and device of expanded polytetrafluoroethylene tube membrane and application of preparation method and device | ZHEJIANG SCI-TECH UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12616948-B2 | Polyamide microcapsules | FIRMENICH SA (CH) | 2026-05-05 | — | — | US | claimed |
| US-20250302760-A1 | BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES | ENCAPSYS, LLC (US) | 2025-10-02 | — | — | US | claimed |
| CN-119931028-A | Novel aramid polymer | 烯驰科技河北有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119425424-A | Polyamide composite membrane based on nanobubble-assisted free interface polymerization strategy and preparation method and application thereof | 中国海洋大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2024250573-A1 | REVERSE OSMOSIS MEMBRANE PREPARATION METHOD AND REVERSE OSMOSIS MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2024-12-12 | — | — | WO | claimed |
| CN-118949689-A | Amphoteric ion modified fluorine-containing poly (ester) amide thin layer composite reverse osmosis membrane, and preparation method and application thereof | 天津工业大学绍兴柯桥研究院 | 2024-11-15 | — | — | CN | claimed |
| US-20240375074-A9 | POLYAMIDE MICROCAPSULES | FIRMENICH & CIE (CH) | 2024-11-14 | — | — | US | claimed |
| CN-118892750-A | Preparation method of environment-friendly functional molecule-mediated ammonia nitrogen interception type ultrathin polyamide reverse osmosis membrane | 哈尔滨工业大学 | 2024-11-05 | — | — | CN | claimed |
| US-12121868-B2 | Doubly porous multi-layer desal membrane | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-10-22 | — | — | US | claimed |
| WO-2020127743-A1 | POLYAMIDE MICROCAPSULES | FIRMENICH SA (CH) | 2020-06-25 | — | — | WO | claimed |
| US-9889413-B2 | Polyetherimide composite nanofiltration membrane and preparation method thereof | TIANJIN UNIVERSITY (CN) | 2018-02-13 | — | — | US | claimed |
| US-20170157574-A1 | POLYETHERIMIDE COMPOSITE NANOFILTRATION MEMBRANE AND PREPARATION METHOD THEREOF | TIANJIN UNIVERSITY (CN) | 2017-06-08 | — | — | US | claimed |
| US-20120255898-A1 | SEMIPERMEABLE POLYMERS AND METHOD FOR PRODUCING SAME | ELTRON RESEARCH & DEVELOPMENT, INC. (US) | 2012-10-11 | — | — | US | claimed |
| WO-2010042250-A2 | SEMIPERMEABLE POLYMERS AND METHOD FOR PRODUCING SAME | ELTRON RESEARCH AND DEVELOPMENT, INC. (US) | 2010-04-15 | — | — | WO | claimed |
| US-20100006495-A1 | SEMIPERMEABLE POLYMERS AND METHOD FOR PRODUCING SAME | ELTRON RESEARCH AND DEVELOPMENT, INC. (US) | 2010-01-14 | — | — | US | claimed |
| EP-1149836-B1 | Polynalbuphine derivatives | HU OLIVER YOA PU (TW) | 2003-02-26 | — | — | EP | claimed |
| EP-0198202-B1 | NOVEL N-CYCLOHEXYL-POLYCARBOXAMIDE COMPOUND AND DERIVATIVES THEREOF, PROCESSES FOR PREPARING THEM, AND USE OF THEM IN PREPARATION OF HOST-GUEST COMPLEXES | MITSUBISHI CORPORATION (JP) | 1991-07-17 | — | — | EP | claimed |
| EP-0198202-A2 | Novel N-cyclohexyl-polycarboxamide compound and derivatives thereof, processes for preparing them, and use of them in preparation of host-guest complexes | MITSUBISHI CORPORATION (JP) | 1986-10-22 | — | — | EP | claimed |
| US-4582893-A | Aromatic polyesters which contain terminal or lateral radicals with two conjugated double bonds | BAYER AKTIENGESELLSCHAFT (DE) | 1986-04-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616948-B2 | Polyamide microcapsules | HDHD5, DDC, USP39 | ALDH1A1 4007/4885ALOX15 3255/4885MAOB 3395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.